Ultragreen Ai (FRA:U5T) Stock Based Compensation: €0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:U5T Ultragreen Ai Ltd FRA:U5T
31 GF Score
Price €1.04
! 1 Warning Sign
View Full Analysis

What is Ultragreen Ai Stock Based Compensation?

Ultragreen Ai FRA:U5T -4.59% 31 Stock Based Compensation is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:U5T with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Ultragreen Ai's Stock Based Compensation for the six months ended in Jun. 2026 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was €0.0 Mil.

Ultragreen Ai Stock Based Compensation Related Terms

Ultragreen Ai Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Ultragreen Ai's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultragreen Ai Stock Based Compensation Chart

Ultragreen Ai Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
0.00 0.00 0.00 0.00

Ultragreen Ai Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
FRA:U5T
31GF Score
Ultragreen Ai Ltd FRA:U5T
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ultragreen Ai Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

What does a Stock Based Compensation of €0.0 Mil mean?
Ultragreen Ai (FRA:U5T) has a Stock Based Compensation of €0.0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Ultragreen Ai and its competitors.
Is Ultragreen Ai's Stock Based Compensation too high?
Ultragreen Ai's current Stock Based Compensation is €0.0 Mil. Overall, Ultragreen Ai has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Ultragreen Ai's Stock Based Compensation compare to VEEV and BTSG?
Ultragreen Ai's Stock Based Compensation of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Ultragreen Ai and its competitors. Ultragreen Ai's current Stock Based Compensation is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultragreen Ai stock overvalued right now?
Ultragreen Ai (FRA:U5T) has a current Stock Based Compensation of €0.0 Mil. The current Stock Based Compensation is €0.0 Mil. Ultragreen Ai's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Ultragreen Ai (FRA:U5T), the current Stock Based Compensation is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ultragreen Ai Business Description

Other Exchanges ULG:Singapore
Address 463 MacPherson Road, M463, Singapore, SGP, 368181
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
31GF Score

Get the complete analysis for FRA:U5T

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price